Join
Live feed
·
PRReleasevia Quantisnow
TC BioPharm (Holdings) plc logo

TCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 Patients

ByQuantisnow·Wall Street's wire, on your screen.
TCBP· TC BioPharm (Holdings) plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TCBP (TC BioPharm (Holdings) plc) and more on Quantisnow.